Mirion Bundle
Who Owns Mirion Technologies?
Understanding Mirion Technologies' ownership is key to grasping its market position and strategic path. As a global leader in radiation detection and measurement, the company plays a vital role in sectors like nuclear power and defense.
Mirion Technologies became a publicly traded entity on the NYSE in October 2021 following a SPAC merger. This transition from private ownership to public listing significantly altered its shareholder landscape.
The ownership of Mirion Technologies is primarily held by institutional investors following its public listing. Key shareholders include investment firms and funds that manage assets on behalf of a broad base of investors. These institutions play a significant role in the company's governance and strategic decisions, influencing its direction in areas such as nuclear energy advancements and medical applications, including products like those detailed in the Mirion PESTEL Analysis. The company, employing around 2,800 people across 12 countries, operates with a focus on protecting people and the environment from radiation hazards.
Who Founded Mirion?
The ownership of Mirion Technologies does not stem from traditional individual founders. Instead, its origins are linked to the Health Physics Division of Canberra Industries. The pivotal ownership transition occurred in 1999 when Charterhouse Capital Partners, a private equity firm, acquired this division, initiating the path towards Mirion Technologies.
| Ownership Milestone | Year | Key Entity | Significance |
|---|---|---|---|
| Acquisition of Health Physics Division | 1999 | Charterhouse Capital Partners | Initial private equity ownership and foundation for Mirion |
| First Investment in Mirion | 2015 | Charterhouse Capital Partners | Significant role in platform expansion and diversification |
Charterhouse Capital Partners provided the initial capital and strategic direction for the spin-off. This private equity firm effectively acted as the foundational owner and early investor in the company's formative years.
Charterhouse Capital Partners made their first investment in Mirion in 2015. This investment preceded the company's public listing and was instrumental in its subsequent development.
During Charterhouse's ownership, Mirion underwent substantial platform expansion. This period also saw significant business transformation, including strategic acquisitions.
Strategic acquisitions during the Charterhouse era diversified Mirion's business operations. The company expanded its reach into the medical and life sciences sectors.
Thomas D. Logan has been a continuous leader, serving as CEO since 2005. His extensive tenure has been crucial for the company's strategic direction and growth.
Thomas D. Logan assumed the role of Chairman of the Board in February 2025. This appointment underscores his deep involvement and leadership within the company's governance.
Thomas D. Logan, while not a founder in the traditional sense of establishing the initial entity, has played a pivotal role in Mirion's trajectory. His leadership as Chief Executive Officer since 2005 and his subsequent appointment as Chairman of the Board in February 2025 highlight his significant influence. Logan's career, which includes over 30 years in the energy industry and experience in contract manufacturing and consumer products, has been instrumental in shaping Mirion's strategic direction and operational success, as detailed in the Growth Strategy of Mirion.
Mirion Technologies' ownership structure evolved from a division acquisition by private equity. Key figures and entities have guided its transformation and expansion over the years.
- Charterhouse Capital Partners initiated ownership in 1999.
- Charterhouse invested significantly in 2015, supporting growth.
- Thomas D. Logan has served as CEO since 2005 and Chairman since February 2025.
- Logan's extensive industry experience has been vital to the company's strategic development.
Mirion SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
How Has Mirion’s Ownership Changed Over Time?
Mirion Technologies' ownership journey saw a significant shift with its public debut in October 2021, moving from a privately held entity to a publicly traded company. This transition was facilitated by a business combination with a SPAC, injecting substantial capital and altering its shareholder base.
| Ownership Type | Percentage (August 2025) | Value (March 2025) |
|---|---|---|
| Institutional Investors | Approximately 80.03% | $1.47 billion (combined value of top 3) |
| Individuals | Approximately 5.16% | N/A |
| Other Entities | Approximately 7.24% | N/A |
Before its public offering, Mirion Technologies was primarily owned by Charterhouse Capital Partners LLP, which had been a significant investor since 2015. The company's transition to a public entity on October 21, 2021, involved a business combination with GS Acquisition Holdings Corp II (GSAH). This strategic move generated approximately $604 million from GSAH trust proceeds, $900 million from a private placement of common stock (PIPE), and $830 million from senior secured term loan financing. A substantial $1.3 billion of these funds were allocated to existing Mirion stockholders, including Charterhouse, which maintained a stake of about 12% in Mirion's common stock following the transaction. This event marked a pivotal moment in Mirion Technologies' company history ownership, setting the stage for its current market presence.
As of recent filings, institutional investors are the dominant force in Mirion Technologies' ownership structure. These entities play a crucial role in the company's financial landscape and strategic direction.
- Vanguard Group: Holds 23 million shares, valued at approximately $337 million as of March 2025.
- BlackRock, Inc.: Owns 16 million shares, with a valuation of around $234 million in March 2025.
- Janus Henderson Group: Possesses 8.6 million shares, valued at approximately $126 million as of March 2025.
- Other significant institutional investors, including T. Rowe Price Investment Management Inc. and Dimensional Fund Advisors LP, have also increased their holdings in the first quarter of 2025, contributing to the overall institutional ownership which reached 86.05% by June 2025. This robust institutional backing provides Mirion Technologies with capital for its growth and innovation initiatives. For a deeper dive into the company's past, explore the Brief History of Mirion.
Mirion PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
Who Sits on Mirion’s Board?
The Board of Directors at Mirion Technologies is instrumental in guiding the company's strategic direction and ensuring robust corporate governance. As of February 2025, Thomas D. Logan holds the dual roles of CEO and Chairman of the Board. The board is comprised of individuals with diverse backgrounds, including operational leadership and experience in various industrial and healthcare sectors, aiming to provide comprehensive oversight.
| Director Name | Role | Key Background |
|---|---|---|
| Thomas D. Logan | Chairman and CEO | CEO since 2005 |
| Kenneth C. Bockhorst | Lead Independent Director | Extensive operational experience in diversified industrial companies |
| Jody A. Markopoulos | Independent Director | Operating leadership at General Electric |
| Robert A. Cascella | Independent Director | Experience on public company boards in medical device and healthcare sectors |
Mirion Technologies adheres to a one-share-one-vote principle for its common stock, meaning each share of common stock carries equal voting rights. As of March 17, 2025, the company had 225,195,204 shares of Class A common stock and 6,379,885 shares of Class B common stock outstanding, with both classes voting as a single unit. Institutional investors held approximately 78.51% of the company's stock as of August 2025, indicating a significant influence on governance decisions through their collective holdings. The decision to combine the CEO and Chairman roles, effective February 2025, was made by the Nominating and Corporate Governance Committee, deemed to be in the best interest of the company and its stakeholders.
Understanding Mirion Technologies ownership structure is key to grasping its governance framework. The board's composition reflects a commitment to diverse expertise, crucial for effective oversight.
- Mirion Technologies operates under a one-share-one-vote system.
- Institutional investors hold a substantial portion of the company's shares.
- The CEO also serves as the Chairman of the Board.
- Board members bring varied experience from industrial and healthcare sectors.
- This structure influences Mirion Technologies company history ownership.
Mirion Business Model Canvas
- Complete 9-Block Business Model Canvas
- Effortlessly Communicate Your Business Strategy
- Investor-Ready BMC Format
- 100% Editable and Customizable
- Clear and Structured Layout
What Recent Changes Have Shaped Mirion’s Ownership Landscape?
Mirion Technologies has undergone significant financial restructuring and strategic acquisitions in the past 12-18 months. These moves aim to strengthen its market position and optimize its capital structure, reflecting a dynamic approach to growth and operational efficiency.
| Development | Date | Amount |
| Convertible Notes Offering | Q2 2025 | $400 million |
| Acquisition of Certrec | July 2025 | $81 million |
| CEO Share Sale (Thomas D. Logan) | August 2025 | $10.74 million |
| Director Share Sale (Lawrence Kingsley) | May 2025 | $8.97 million |
Recent developments indicate a strategic focus on financial health and expansion. Mirion Technologies completed a $400 million convertible notes offering and refinanced its Term Loan B in the second quarter of 2025. These actions build upon 2024 efforts to simplify its capital structure, including warrant redemption and founder share vesting. The acquisition of Certrec for $81 million in July 2025 further bolsters its offerings in the nuclear power sector.
Key executives, including CEO Thomas D. Logan and Director Lawrence Kingsley, sold shares in August and May 2025 respectively, totaling over $19 million. These transactions were conducted under pre-arranged 10b5-1 trading plans.
Despite insider sales, institutional investors are increasing their stakes. Firms like Lord Abbett & CO. LLC, T. Rowe Price Investment Management Inc., and Brown Advisory Inc. have expanded their holdings, with institutional shareholding reaching 86.05% as of June 2025.
The acquisition of Certrec for $81 million in July 2025 enhances Mirion's nuclear power capabilities. The company reported a 7.6% revenue increase to $222.9 million in Q2 2025, with adjusted EPS of $0.11, leading to an upward revision of full-year 2025 guidance.
Mirion's proactive strategy aligns with growth in nuclear power and cancer care sectors. The company's financial performance and M&A activities suggest a strong trajectory, positioning it to capitalize on favorable market conditions. Understanding this landscape is crucial when examining the Competitors Landscape of Mirion.
Mirion Porter's Five Forces Analysis
- Covers All 5 Competitive Forces in Detail
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
- What is Brief History of Mirion Company?
- What is Competitive Landscape of Mirion Company?
- What is Growth Strategy and Future Prospects of Mirion Company?
- How Does Mirion Company Work?
- What is Sales and Marketing Strategy of Mirion Company?
- What are Mission Vision & Core Values of Mirion Company?
- What is Customer Demographics and Target Market of Mirion Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.